Assembly Historical Income Statement
| ASMB Stock | USD 13.15 0.34 2.65% |
Historical analysis of Assembly Biosciences income statement accounts such as Interest Expense of 544.1 K, Selling General Administrative of 17.7 M or Other Operating Expenses of 61 M can show how well Assembly Biosciences performed in making a profits. Evaluating Assembly Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Assembly Biosciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Assembly Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Assembly Biosciences is a good buy for the upcoming year.
Assembly |
About Assembly Income Statement Analysis
Assembly Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Assembly Biosciences shareholders. The income statement also shows Assembly investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Assembly Biosciences Income Statement Chart
Assembly Biosciences Income Statement is one of the three primary financial statements used for reporting Assembly's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Assembly Biosciences revenue and expense. Assembly Biosciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Assembly Biosciences' Income Tax Expense is projected to decrease significantly based on the last few years of reporting. The current year's Total Other Income Expense Net is expected to grow to about 3.6 M, whereas Depreciation And Amortization is forecasted to decline to about 427.5 K. Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Assembly Biosciences. It is also known as Assembly Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Most accounts from Assembly Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Assembly Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assembly Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.At present, Assembly Biosciences' Income Tax Expense is projected to decrease significantly based on the last few years of reporting. The current year's Total Other Income Expense Net is expected to grow to about 3.6 M, whereas Depreciation And Amortization is forecasted to decline to about 427.5 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 302K | 1.0M | 2.4M | 1.6M | Net Interest Income | 302K | 1.0M | 2.4M | 1.6M |
Assembly Biosciences income statement Correlations
Click cells to compare fundamentals
Assembly Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Assembly Biosciences income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 494K | 691K | 83.3M | 498K | 450K | 427.5K | |
| Interest Expense | 4.8M | 2.6M | 82.5M | 498K | 572.7K | 544.1K | |
| Selling General Administrative | 32.9M | 37.1M | 28.8M | 24.1M | 22.9M | 17.7M | |
| Other Operating Expenses | 118.7M | 143.9M | 97.3M | 94.1M | 71.8M | 61.0M | |
| Operating Income | (102.7M) | (64.8M) | (132.7M) | (94.1M) | (64.6M) | (67.9M) | |
| Ebit | (102.7M) | (64.8M) | (132.7M) | (94.1M) | (64.6M) | (67.9M) | |
| Research Development | 85.8M | 106.8M | 68.5M | 70.0M | 48.9M | 43.3M | |
| Ebitda | (102.2M) | (64.1M) | (49.4M) | (93.6M) | (64.2M) | (67.4M) | |
| Total Operating Expenses | 118.7M | 143.9M | 97.3M | 94.1M | 71.4M | 61.0M | |
| Net Income | (97.6M) | (59.5M) | (129.9M) | (92.1M) | (61.2M) | (64.3M) | |
| Income Tax Expense | (774K) | (2.6M) | (2.5M) | (1.0M) | 33K | 34.7K | |
| Income Before Tax | (98.4M) | (62.2M) | (132.4M) | (93.1M) | (61.2M) | (64.3M) | |
| Total Other Income Expense Net | 4.3M | 2.6M | 302K | 1.0M | 3.5M | 3.6M | |
| Total Revenue | 14.8M | 16.0M | 79.1M | 6.3M | 7.2M | 11.2M | |
| Gross Profit | 16.0M | 79.0M | 5.8M | (498K) | 6.7M | 7.0M | |
| Net Income From Continuing Ops | (97.6M) | (62.2M) | (129.9M) | (93.1M) | (72.7M) | (76.3M) | |
| Cost Of Revenue | 85.8M | 101.3K | 466K | 498K | 450K | 427.5K | |
| Non Operating Income Net Other | 3.1M | 4.3M | 2.6M | 1.0M | 1.2M | 1.3M | |
| Net Income Applicable To Common Shares | (97.6M) | (62.2M) | (129.9M) | (93.1M) | (83.8M) | (88.0M) | |
| Tax Provision | (774K) | (741K) | (2.5M) | 0.0 | 33K | 34.7K | |
| Net Interest Income | 4.3M | 2.6M | 302K | 1.0M | 2.4M | 1.6M | |
| Interest Income | 4.3M | 2.6M | 302K | 1.0M | 2.4M | 1.6M | |
| Reconciled Depreciation | 494K | 691K | 466K | 498K | 490K | 550.2K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Assembly Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Assembly Biosciences' short interest history, or implied volatility extrapolated from Assembly Biosciences options trading.
Pair Trading with Assembly Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Assembly Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assembly Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Assembly Stock
| 0.63 | LGVN | Longeveron LLC Earnings Call This Week | PairCorr |
| 0.62 | IMCR | Immunocore Holdings Financial Report 8th of May 2024 | PairCorr |
| 0.55 | IMRX | Immuneering Corp Earnings Call This Week | PairCorr |
| 0.53 | TXG | 10X Genomics | PairCorr |
| 0.5 | GILD | Gilead Sciences | PairCorr |
The ability to find closely correlated positions to Assembly Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Assembly Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Assembly Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Assembly Biosciences to buy it.
The correlation of Assembly Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Assembly Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Assembly Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Assembly Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assembly Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Assembly Stock analysis
When running Assembly Biosciences' price analysis, check to measure Assembly Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assembly Biosciences is operating at the current time. Most of Assembly Biosciences' value examination focuses on studying past and present price action to predict the probability of Assembly Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assembly Biosciences' price. Additionally, you may evaluate how the addition of Assembly Biosciences to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Assembly Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assembly Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.38) | Revenue Per Share 1.565 | Quarterly Revenue Growth (1.00) | Return On Assets (0.34) | Return On Equity (0.99) |
The market value of Assembly Biosciences is measured differently than its book value, which is the value of Assembly that is recorded on the company's balance sheet. Investors also form their own opinion of Assembly Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Assembly Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assembly Biosciences' market value can be influenced by many factors that don't directly affect Assembly Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assembly Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assembly Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.